Article
Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation
9 Oct 2015
Abstract excerpt
BACKGROUND: The oncogenic transcription factor MYC is pathologically activated in many human malignancies. A paradigm for MYC dysregulation is offered by Burkitt lymphoma, where chromosomal translocations leading to Immunoglobulin gene-MYC fusion are the crucial initiating oncogenic events. However, Burkitt lymphoma cases with no detectable MYC rearrangement but maintaining MYC expression have been identified and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
